Susan Sharpe, MD, General Surgery, Cleveland, OH, MetroHealth Medical Center

SusanMargueriteSharpeMD, FACS

General Surgery Cleveland, OH

Surgical Oncology (Other than Breast)

Physician

Dr. Sharpe is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sharpe's full profile

Already have an account?

Summary

  • Board-certified in General Surgery and Complex General Surgical Oncology surgeon able to collaborate with multi-disciplinary healthcare teams and has interests in resident and student education and clinical outcomes research. I have successfully applied for access to and utilized national databases resulting in publications in peer-reviewed surgical journals and presentations at national meetings, and am proficient in electronic medical record systems.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, 2012 - 2015
  • Rutgers-NJMS
    Rutgers-NJMSResidency, General Surgery, 2005 - 2012
  • George Washington University School of Medicine
    George Washington University School of MedicineClass of 2005
  • Drexel UniversityBS, Bioscience, Summa cum laude, 1996 - 2001

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2020 - 2023
  • OH State Medical License
    OH State Medical License 2015 - 2022
  • IL State Medical License
    IL State Medical License 2012 - 2017
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Collaborative Cancer Treatment Network Advances Despite Pandemic Slowdown
    Collaborative Cancer Treatment Network Advances Despite Pandemic SlowdownJuly 20, 2020 09:30
  • Banner Life Sciences Announces Commercial Launch of BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis
    Banner Life Sciences Announces Commercial Launch of BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple SclerosisJuly 17, 2020 09:41
  • Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple SclerosisMay 01, 2020 09:52

Professional Memberships

Hospital Affiliations